Will Farmmi Inc. (NASDAQ:FAMI) Stock Recover After The Recent Sharp Correction?

Farmmi Inc. (NASDAQ:FAMI) is down 5% in a week. Last week the company announced that its subsidiary, Zhejian Forest Food Co. Ltd., had won a product export order to Israel. The sales order win is for dried sliced and whole Shiitake mushrooms plus dried black fungus. CEO and chairwoman of the company Ms. Yefang Zhang said they have come from a demanding period, and they are ready for customer development,…

Read More >>

Is Globalstar (NYSEAMERICAN:GSAT) Stock a Buy Or Sell After The Recent Consolidation?

Globalstar’s (NYSEAMERICAN:GSAT) stock could break out soon as its partnerships blossom. The company’s Q2 results were disappointing, with revenue declining and operational losses increasing YoY. However, even though the results were disappointing, share prices move up, attributed to improving losses. Notably, a bullish position on GSAT depends on intuitions regarding its prospects instead of relying on fundamentals alone. For instance, news about its past deals makes GSAT worth watching. For…

Read More >>

SOS Ltd (NYSE:SOS) Stock Has Soared 120% YTD: How Can You Trade Now?

SOS Ltd (NYSE: SOS) has seen considerable interest from investors because of its connection to crypto mining. The company recently upgraded its website, but that has done less to inspire confidence in the stock. In the crypto and blockchain, the sect where SOS operates, transparency is vital, and the primary appeal of crypto, defi, and blockchain is information decentralization.  Unfortunately, SOS falls short when it comes to transparency, and despite…

Read More >>

Senseonics Holdings Inc. (SENS) Stock In Focus: How to Trade Now?

Senseonics Holdings Inc. (NYSEAMERICAN:SENS) fell 6.5% after announcing its financial results for the quarter ending June 30, 2021, revenue was $3.3 million. During the quarter, Ascencia Diabetes Care unveiled a US patient assistance program and direct-to-consumer online ad campaign. The patient assistance program sought to reduce out-of-pocket payments for diabetes patients, including the more than 200 million already covered. The ad campaign was to raise Eversense awareness and create new…

Read More >>

Pixelworks Inc. (NASDAQ:PXLW) Stock Sees Buying Interest At Lower Levels: More to Come?

Pixelworks Inc. (NASDAQ:PXLW) jumped 15.5% after announcing 50% sequential and YOY growth in revenue in Q2 2021. The growth is attributable to string projector business recovery and continued growth in mobile revenue. Mobile revenue increased QOQ and YOY driven by enhanced adoption of software and hardware-based visual processing solutions in the increasing number of smartphone launches. ASUS unveiled Zenfone 8 flip and Zonefone 8 flagship phones that incorporate the company’s…

Read More >>

Xenetic BioSciences Inc. (NASDAQ:XBIO) Stock Sees Solid Buying Interest: Buy Now?

Xenetic BioSciences Inc. (NASDAQ:XBIO) jumped 14%. Recently, the company signed a sale and purchased a definitive agreement to purchase 4.63 million of its common shares by a healthcare-focused institutional investor. The company is offering the shares at $2.7 per share in an at-the-market private placement under the Nasdaq rules. Equally, the company agreed to provide the investor share purchase warrants to buy 4.63 million common shares. Notably, the contracts have…

Read More >>

NewAge Inc. (NASDAQ:NBEV) Stock Gains Momentum: How Far Can it Go?

NewAge Inc. (NASDAQ:NBEV) jumped 14% after announcing its Q2 2021 financial results, in which net revenue was $124 million. The company reported adjusted EBITDA of around $1.7 million, net income of $17.4 million, and basic EPS of $0.11. Net revenue increased 98% compared to a year ago. CEO Brent Willis said that Q2 2021 saw an increase in the bottom and topline results. Brent said that during the quarter, the…

Read More >>

Ziopharm Oncology Inc. (NASDAQ:ZIOP) Stock Takes a Hit: A Good Buy Now?

Ziopharm Oncology Inc. (NASDAQ:ZIOP) fell 16% after announcing Q2 2021 corporate updates. Interim CEO Heidi Hagen said that Ziopharm had made considerable progress on various fronts since the last update. The company had built positive momentum in the TCR-T Library clinical study enabling activities and strengthening the balance sheet. He explained that the quarterly update shows that the company is on track with what it had early set to attain….

Read More >>

Waitr Holdings Inc. (NASDAQ:WTRH) Stock Slumps After Earnings: Better to Avoid?

Waitr Holdings Inc. (NASDAQ:WTRH) fell 23% after the company missed Q2 estimates. The company announced revenue of $49.2 million in Q2 2021 comp-pared to $60.5 million a year ago. For the six months ending June 30, 2021, the company generated revenue of $100.1 million. Waitr reported an increase of average daily orders to 38,583 with active diners at the end of the quarter, consistent with the numbers reported in Q1…

Read More >>

Diffussion Pharma Inc. (NASDAQ:DFFN) Stock Attempts To Rebound: How to Trade Now?

Diffussion Pharma Inc. (NASDAQ:DFFN) jumped 4.5% on no company-specific news or release. Recently, the company released a topline result for the phase 1 study of its flagship product, trans sodium crocetinate (TSC). The company used transcutaneous oxygen monitoring hg in the trial to assess direct TSC pharmacodynamics effects on peripheral oxygenation of tissue in healthy individuals. The topline findings were based on primary endpoint data analysis which showed a promising…

Read More >>
x